Abdul-Ghani, M., Del Prato, S., Chilton, R., & DeFronzo, R. A. (2016). SGLT2 Inhibitors and Cardiovascular Risk: Lessons Learned From the EMPA-REG OUTCOME Study. Diabetes Care.
シカゴスタイル引用形Abdul-Ghani, Muhammad, Stefano Del Prato, Robert Chilton, , Ralph A. DeFronzo. "SGLT2 Inhibitors and Cardiovascular Risk: Lessons Learned From the EMPA-REG OUTCOME Study." Diabetes Care 2016.
MLA引用形式Abdul-Ghani, Muhammad, Stefano Del Prato, Robert Chilton, , Ralph A. DeFronzo. "SGLT2 Inhibitors and Cardiovascular Risk: Lessons Learned From the EMPA-REG OUTCOME Study." Diabetes Care 2016.
警告: この引用は必ずしも正確ではありません.